Scientists uncover how superbug fights off antibiotic.
Thousands of people succumb to superbug-related infections worldwide annually and superbugs account for $20 billion in excess health care costs in the United States each year.
“Antibiotic resistance is one of the major public health threats of the 21st Century,” said Cesar Arias, M.D., Ph.D., the study’s senior author and associate professor in the Division of Infectious Diseases at the UTHealth Medical School. “These superbugs can make antibiotics useless, which makes certain bacterial infections virtually untreatable.”
Antibiotics, PPIs may fuel community-associated C. difficile
Prevention of community-associated CDI should primarily focus on reducing inappropriate antibiotic use and better infection control practices in outpatient settings. Our data support evaluation of additional strategies, including further examination of C. difficile transmission in outpatient and household settings and reduction of PPI use,’ the investigators concluded.
The CDC funded the work. The authors reported no conflicts of interest.”
Killer found in Ocean
A new antibiotic, Anthracimycin, has been discovered and can kill Anthrax (Bacillus anthracis) as well as MRSA (methicillin-resistant Staphylococcus aureus.